The purpose of this study was to design and evaluate the performance of an Ultra-fast 
Introduction
The formulation of advanced rapidly disintegrating oramucosal drug delivery systems is lucrative due to the oral route being the most effective means of administering medication to patients [1] [2] [3] . A large degree of this route's success lies in its convenience and relative noninvasiveness, resulting in a high degree of patient compliance. Despite its advantages, conventional oral drug delivery is still subject to various shortcomings such as the loss of drug as a result of the hepatic 'first-pass' effect as well as the chemical degradation of sensitive pharmaceutical actives in the gastrointestinal tract 4, 5 . The inability of certain patient groups (such as the physically and mentally disabled, pediatrics and geriatrics) to swallow a tablet or capsule also places additional constraints upon oral drug delivery 6, 7 .
In an attempt to circumvent a few of the disadvantages still associated with oral delivery systems, a variety of rapidly disintegrating drug delivery systems have been developed.
These specialized formulations dissolve in the patient's mouth within a few seconds to minutes 2, [8] [9] [10] [11] . This provides the convenience of a tablet or capsule while simultaneously allowing for the ease of swallowing provided by a liquid formulation 12, 13 . Generally, when this dosage form is placed in the mouth, contact with saliva causes it to disintegrate almost immediately into tiny particles, resulting in liberation of the drug molecules, which can thereafter be absorbed through the oramucosa. However, further exposure to saliva results in the particles dissolving into a drug-loaded suspension, which is then swallowed, exposing the drug to the gastric environment prior to conventional oral drug absorption and first-pass metabolism. Pre-gastric absorption therefore results in increased bioavailability of the drug since the potentially destructive gastric environment and hepatic metabolism is bypassed 14 .
Wafer drug delivery is an advancing field which represents highly versatile polymeric devices consisting of porous matrices that allow for rapid delivery of drugs. Most wafers are produced via lyophilization, a process key to its rapidly disintegrating properties. The removal of unbound moisture from the wafer during the lyophilization process creates voids within the matrix resulting in the formation of a porous network which facilitates disintegration when exposed to the hydrophilic, saliva-rich oral cavity. In addition to being relatively costeffective and simple to manufacture, wafers are also a highly efficient, versatile, and effective means of drug delivery. This is largely due to the ability of using wafers via the oral route to provide patients with quick, easy, and non-invasive pharmacological relief.
This study provides for the design, development and evaluation of an orally administered
Ultra-fast Disintegrating Wafer (U-D-WAF) capable of delivering drug in an instantaneous
manner, through the buccal mucosa, into systemic circulation. Enhanced U-D-WAF disintegration was been achieved by using hydrophilic hydroxypropylcellulose (HPC) as one of the primary matrix-forming agents. HPC provides a physically robust matrix while still maintaining the desired rapid disintegration properties of the product 15 . HPC gels, either alone or in combination with other polymers, also avail varying degrees of bioadhesivity from which drugs have the potential to be constantly released. β-cyclodextrin (β-CD) was used for taste-masking effects, whilst Sodium Starch Glycolate (SSG) was employed for its disintegrant properties.The U-D-WAF, as part of this study, has been statistically optimized using an experimental design prior to extensive in vitro and in vivo characterization in the Large White pig model. In addition, for the first time this study explores the oramucosivity (mucoadhesivity to the oramucosa) employing detailed molecular modeling of the U-D-WAF matrix on buccal tissue to mechanistically ascertain the mucodhesive properties of the U-D-WAF after exposure to the oramucosa. 16 . The resulting solution was analyzed using UV spectroscopy at 254 nm. Drug content was assessed using Equation 1:
Materials and methods

Materials
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Disintegration studies
Rapid disintegration studies were undertaken on the U-D-WAF formulations using the method as outlined by El-Arini et al. 17 with modifications. A Texture Analyzer (TA.XTplus Stable Microsystems, Surrey, UK) equipped with a flat, cylindrical probe (20 mm diameter), was used to mimic the tongue's influence on the U-D-WAF. Individual wafers (n=3) were pre-weighed and the probe pre-wetted with Simulated Saliva (SS) onto which the U-D-WAF was affixed. The wetting of the probe provided sufficient moisture for the U-D-WAF face to undergo a minimal amount of gellation, thus requiring no other means of attachment. The sample was then lowered into a mini-petri dish (3.5 cm diameter) containing 1.5 mL SS (pH 6.75, 37±0.5 °C) at a predetermined force for 60 s. Disintegration was regarded to be complete when total loss of U-D-WAF structure was evident and the matrix had collapsed.
The resultant distance-time profile was used to determine the onset of disintegration (time at the onset of rapid increase of distance), disintegration rate (the first gradient of the descending region from the onset of disintegration before the point of inflection where disintegration rate decreased or stopped), and penetration distance of the probe through the wafer (initial distance prior to onset of disintegration).
Physicomechanical integrity analysis
All physicomechanical integrity analysis studies (n=3) were conducted using the TA.XTplus
Texture Analyzer fitted with a 5 kg load cell and a stainless steel needle-point probe. The testing parameters were configured such that the tip of the needlepoint probe passed completely through the center of the wafer matrix at a pre-determined force (0.098N). 
Surface morphological studies
The surface morphology of U-D-WAF was determined using a FEI Phenom TM G2 Pro
Desktop Scanning Electron Microscope (SEM) (Hillsboro, OR, USA). Each sample was mounted on aluminum stubs and sputter-coated with gold-palladium under a vacuum of 0.5
Torr (SPI-MODULE™ Control, SPI Supplies, PA, USA) prior to visualization.
Rheological analysis
Rotational rheometry was conducted on the gel-like residue that remained upon conclusion of disintegration testing, using a Haake Modular Advanced Rheometer System (ThermoFisher Scientific, Germany) at 37 °C. The profiles generated by the RheoWin ® operating software were analyzed for shear stress, viscosity and deformation as a function of shear rate and time respectively. For analysis, the gel sample (n=3) was carefully loaded onto the rheometer plate in such a manner that shearing was minimal . The average shear rate within the human oral cavity is reported to be between 0.1-1000 s -1
. Shear stress and deformation was measured as a function of the shear rate.
Ex vivo drug permeation analysis
Porcine buccal mucosa, obtained from a local abattoir (Mintko Meat Packers, Krugersdorp, Gauteng, South Africa), was used as a substitute for human oramucosal tissue for all ex vivo studies. All buccal tissue was excised in accordance with Good Laboratory Practice (GLP) standards and the methods outlined by Giannola et al. 20 before being flash frozen in liquid nitrogen and stored at -70 °C until use 20, 21 . The integrity of the porcine buccal mucosa was maintained during sourcing, storage and conduction of this analysis. This was done in accordance with the respective GLP protocols and standards. All ex vivo release studies were conducted using a Franz Diffusion Apparatus, equipped with a 12mL receptor compartment. For this analysis, excised porcine buccal mucosa was sandwiched between the donor compartment, containing SS (pH 6.75) and the U-D-WAF to mimic the buccal cavity, and the receiver compartment containing simulated plasma (37 °C; pH 7.4) 22 to mimic the systemic circulation. The porcine mucosa was allowed to defrost to room temperature prior to analysis. Samples (1 mL) from the receiver compartment were drawn after 20, 60, 180, 300, 600, 1800, 3600 and 5400 s, with an equal volume (1 mL) of simulated plasma (pH 7.4, 37±0.5°C) replaced after each sampling to maintain sink conditions. The concentration of drug in the receiver compartment was measured using UV spectroscopy.
In vivo studies in a Large White Pig model
Twelve healthy female Large White pigs (≈35kg) divided equally into 4 groups were used in the in vivo study. Group 1 was designated the control group (administered with no formulation) while groups 2 and 3 served to test the optimized U-D-WAF and the comparator product respectively. Group 4 was used as a placebo group in which U-D-WAF without drug was administered. All study groups were anaesthetized with midazolam (0.3 mg/kg I.M.) and ketamine (11 mg/kg I.M.). Isoflurane (2 %) in oxygen (100 %) was administered via a face mask to maintain anesthesia. subsequently reconstituted with 1 mL DMSO prior to analysis 24, 25 .
Dosing
HPLC analysis
Atomistic molecular structural mechanics simulations
In order to obtain an overall understanding of the underlying mechanisms governing the between the rings gave a regular torus structure of 6-fold symmetry. The structure diphenhydramine (DPH) were built up with natural bond angles as defined in the Hyperchem software. The PAA decamer was drawn using ChemBio3D Ultra in its syndiotactic stereochemistry as a 3D model. The structure of the glycosylated oromucopeptide analogue (MUC; glycosylated Pro-Asp-Thr-Arg sequence) was generated using the sequence editor module on HyperChem 8.0.8. The generation of the overall steric energy associated with the energy-minimized structures was initially executed initially via energyminimization using MM+ force field and the resulting structures were again energyminimized using the Amber 3 (Assisted Model Building and Energy Refinements) force field.
The conformer having the lowest energy was used to create the DPH-β-CD and HPC-PAA complexes.
Two different approaches, lateral alignment and insertion, were adopted for the relative arrangements of DPH and β-CD. In former case, the molecule was further allowed to approach the β-CD cavity laterally from two lateral orientations: the narrower rim which contains the primary hydroxyl groups (β-CD-DPH1) and other from the secondary hydroxyl rim (β-CD-DPH2) (Fig. 1) . In case of insertion model, the complexation arrangement was obtained by the manual insertion of DPH in vertical position into the β-CD cavity, through the primary (β-CD-DPH3) and secondary hydroxyl group rim (β-CD-DPH4) and perpendicularly to its diameter via the phenyl ring end. HPC, PAA and MUC were modelled to generate:
HPC/PAA and HPC/PAA/MUC. Full geometry optimizations were carried out in vacuum employing the Polak-Ribiere conjugate gradient method with several algorithms (at first, steepest descent, followed by conjugate gradient to refine the structure) until an RMS gradient of 0.001kcal/mol was reached. Force field options in the AMBER (with all hydrogen atoms explicitly included) and MM+ (extended to incorporate non-bonded cut-offs and restraints) methods were the HyperChem 8.0.8 defaults. For calculations of energy attributes, the force fields were utilized with a distance-dependent dielectric constant scaled by a factor of 1. The 1-4 scale factors are following: electrostatic 0.5 and van der Waals 0.5. Disintegration profiling of the respective experimental design formulations revealed extended onsets of disintegration despite possessing relatively good disintegration rates and times (Table 1 ). The variation in disintegration rate was noted to be largely dependent on the concentrations of polymers and SSG used. This can be considered as a characteristic behavior of the highly hydrophilic core components within the U-D-WAF that were exploited . As a result of this, SSG presents a decreased surface area for wetting, thus impeding its ability to swell in a hydrophilic medium to exert its Table 2 . This contradicts the traditional image of lyophilized products being structurally unsound and ill-equipped to deal with the rigors of packaging and handling 28 . The average matrix tolerance, resilience and energy of absorbance for Formulation 14 could not be determined due to the properties of the U-D-WAF matrix produced.
RESULTS AND DISCUSSION
Assessment of U-D-WAF Drug Entrapment Efficiency and disintegration
Surface morphology of the U-D-WAF matrices
Scanning electron microscopy images of the respective experimental design formulations noted significant differences in surface morphology, dependent largely on the quantity of the polymeric constituents used. Fig. 3a , which depicts a U-D-WAF formulation with a greater quantity of polymeric constituents, was seen to have decreased surface porosity when compared to the U-D-WAF matrices containing low to medium quantities of polymer solution.
This property is in correlation with the longer disintegration times determined whereby a decreased surface porosity inhibited matrix hydration. Fig. 3b , which depicts a U-D-WAF formulation with a lower quantity of polymeric constituents, in contrast has significantly larger surface pores and therefore hydrates far more quickly. This therefore results in the lower disintegration time seen previously. The degree of mucoadhesivity appeared to decrease with increasing concentrations of SSG. Conversely however, mucoadhesivity increased correspondingly with increasing concentrations of the PAA, whilst increased concentrations of HPC served to merely increase the viscosity of the gel as illustrated in Fig. 4 . The viscous nature of this gel coupled with its ability to withstand a relatively high shear rate further demonstrates its ability to remain undisturbed in the oral cavity, ultimately allowing for constant release of drug.
Response optimization of the U-D-WAF
Ex vivo drug permeation studies
Average cumulative drug permeation of the 15 batches of experimental design U-D-WAFs was determined to be 86.32 % (n=45, SD±20.34) at 60 s (Fig. 5) . Formulations containing lower concentrations of HPC and higher concentrations of SSG were seen to produce almost complete drug permeation within the first minute of testing. The swiftness and completeness of drug release and permeation in such formulations can be attributed to the formulation's rapidly disintegrating nature. When exposed to SS (pH 6.75, 37±0.5°C), the polymeric chains comprising the low viscosity HPC backbone proceed to disentangle in a degree that is proportional to fluid infiltration within the matrix. In addition, SSG is simultaneously wetted with SS, causing it to swell and further contributed towards matrix collapse. Formulations containing relatively higher concentrations of SSG were thus able to more comprehensively assist with matrix disintegration; hence these U-D-WAFs displayed a higher fractional drug release and permeation. PAA's contact with SS results in its swelling to form a hydrated matrix layer in the form of a gel
30
. Instead of entangled polymer chains, PAA forms discrete microgels composed of polymer particles in which the drug is dispersed.
Higher PAA concentrations appear to negatively impact the amount of drug able to be liberated from the U-D-WAF matrix for absorption over the time constraints required for rapid drug release; the viscosity of the microgels produced parallels that of PAA concentrations.
Thus, the more concentrated PAA is, the more viscous the microgel, implying less drug is able to be readily released for systemic absorption. This formulation is, however, capable of releasing embedded drug constantly over an extended time period of approximately 15 min as displayed in the experimental design formulations tested.
I n vivo release analysis
The ) at approximately 300 s (Fig. 6) , high than the ex vivo permeation results that exhibited peak concentrations after 60 s. This disparity can be justified by the anticholinergic side-effects of the sedatives and general anesthetics that were administered to the animals prior to the study which serves to dry secretions, including the comparator product (50mg). Based on the study its conclusive that optimized rapidly disintegrating oramucosal U-D-WAF is able to achieve a greater degree of systemic drug release in a shorter period of time than its comparator product. 
Molecular mechanics assisted model building and energy refinements
A molecular mechanics conformational searching procedure was employed to acquire the data employed in the statistical mechanics analysis, and to obtain differential binding energies of a Polak-Ribiere algorithm and to potentially permit application to drugcyclodextrin and polymer-protein assemblies. MM+ is a HyperChem modification and extension of Norman Allinger's Molecular Mechanics program MM2 31 whereas AMBER, is a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules 32 . where, V∑ is related to total steric energy for an optimized structure, Vb corresponds to bond stretching contributions (reference values were assigned to all of a structure's bond lengths), Vθ denotes bond angle contributions (reference values were assigned to all of a structure's bond angles), Vφ represents torsional contribution arising from deviations from optimum dihedral angles, Vij incorporates van der Waals interactions due to non-bonded interatomic distances, Vhb symbolizes hydrogen-bond energy function and Vel stands for electrostatic energy.
Molecular mechanics energy relationship analysis
DPH-β-CD molecular mechanics simulations at different orientations
The energy minimized structures of the all four orientations of DPH-β-CD following molecular mechanics simulations are depicted in Fig. 7 Fig.7c and 7d . The phenyl rings of DPH were included into the cyclodextrin cavity through the primary hydroxyl groups edge (Fig. 7c) or through the secondary hydroxyl groups edge (Fig. 7d) , which rendered the aliphatic chain closer to primary and secondary edges, respectively.
The DPH insertion through the narrower rim was more favourable as illustrated by the energy characteristics and molecular attributes (Eqns. 3, 4, 7, 8) . As compared to parallel models, β-CD-DPH 3 and β-CD-DPH4, demonstrated higher energy stabilities which accounted for -40.501 kcal/mol and -31.677 kcal/mol, respectively. Furthermore, unlike the parallel models, β-CD-DPH3 and β-CD-DPH4, demonstrated not so close energy stabilities in the form of electrostatic stability. However, the insertion through the secondary ring resulted in a β-CD conformation with torus distortions and may create higher steric hindrance for the penetrant (Fig. 7d) . The results can also be deduced in a way that the phenyl rings are more favoured towards the secondary rim due to availability of more space.
The aforementioned results suggested a possible molecular arrangement for the inclusion Conway, respectively 33, 34 .
Prediction of the mucoadhesive potential of the U-D-WAF
The monomer length for the polymer chain depicting molecular structures of the polymers were determined on the basis of equivalent grid surface area covered by the polymers so that the inherent stereo-electronic factors at the interaction site can be perfectly optimized.
The set of low-energy conformers that were in equilibrium with each other was identified and structure may provide the necessary physicomechanical properties to the U-D-WAF. It may also be responsible for the formation of the porous structure (instead of a continuous polymer structure) which led to the rapid inflow of water in the matrix thereby disintegrating it in a very short time.
We further carried out the molecular computations to ascertain the thermodynamic/energetic changes that may occur due to interaction of the polymeric matrix with the mucosal peptide in the form of HPC/PAA-MUC (Fig. 8b, Eqns. 11-13 ). The energy minimizations were found to be a collective phenomenon including non-bonding interactions in the form of van der Waals forces and electrostatic interactions (Eqns. 9, 10, 11 and 12). Furthermore, the Hbonding between HPC-PAA, HPC-MUC and PAA-MUC contributed to a stress transduction requiring a large fraction of the surface to establish connectivity between chemically transformed regions (Fig. 8b) . The binding energy of the polymer matrix with MUC was highly stabilized at -89.100 kcal/mol confirming the significant interactions among the polymer entities and the oromucopeptide (Fig. 8b and Eqn. 13). The H-bonds formed between the polymer matrix and the MUC further depicts the interaction profile of the polymer and the protein. A deeper inspection shows that the specificity of this complex arises due to hydrophobic interactions of the methyl groups of the mucopeptide residues with oxygen atoms of the polymers (Fig. 8b) .
CONCLUSIONS
The use of the Box-Behnken Design proved to be an invaluable tool in assessing the influence of U-D-WAF matrix constituents upon drug release characteristics of a rapidly disintegrating, low density wafer intended for rapid oramucosal drug delivery. HPC concentration was seen to be a rate-limiting factor for disintegration, correspondingly impacting the drug release and permeation, over a short period of time, to a greater degree compared to either PAA or SSG. PAA demonstrated its ability to slowly release drug over a certain time period but this manipulation of drug release from matrix was demonstrated only after the matrix disintegration had occurred. This finding is critical since it implies the potential to further enhance bioavailability of the model drug as less of the drug will be swallowed as an intra-oral suspension and become lost to conventional digestive processes.
In vivo findings revealed that the drug released from optimized U-D-WAF is more rapidly able to achieve a larger concentration of drug systemically than currently commercially available oral comparator products. Furthermore, the molecular mechanics studies 
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